Oncolytics Biotech (ONCY) Posts Q1 Loss of 6c/Share

Oncolytics Biotech (NASDAQ: ONCY) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral
• Seacoast Banking (SBCF) PT Raised to $34 at Piper Sandler